VISTAGEN THERAPEUTICS, INC. Shareholders' Equity
VISTAGEN THERAPEUTICS, INC. (VTGN) had Shareholders' Equity of $24.48 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-14
- 2026-06-30: Stockholders' Equity Attributable to Parent $24.48M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $35.52M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $50.92M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $66.34M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $24.48M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $35.52M 10-Q · filed 2026-08-14 | |
| 2025-12-31 | $50.92M 10-Q · filed 2026-02-12 | |
| 2025-09-30 | $66.34M 10-Q · filed 2026-02-12 | |
| 2025-06-30 | $56.77M 10-Q · filed 2026-08-14 | |
| 2025-03-31 | $70.39M 10-Q · filed 2026-08-14 | |
| 2024-12-31 | $81.12M 10-Q · filed 2026-02-12 | |
| 2024-09-30 | $92.97M 10-Q · filed 2026-02-12 | |
| 2024-06-30 | $104.80M 10-Q · filed 2026-02-12 | |
| 2024-03-31 | $114.29M 10-K · filed 2026-06-15 | |
| 2023-12-31 | $123.28M 10-Q · filed 2025-02-13 | $123.28M 10-Q · filed 2024-02-13 |
| 2023-09-30 | $35.65M 10-Q · filed 2025-02-13 | $35.65M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $6.85M 10-Q · filed 2025-02-13 | |
| 2023-03-31 | $12.08M 10-K · filed 2025-06-17 | |
| 2022-12-31 | $20.67M 10-Q · filed 2024-02-13 | |
| 2022-09-30 | $29.61M 10-Q · filed 2024-02-13 | |
| 2022-06-30 | $46.05M 10-Q · filed 2024-02-13 | |
| 2022-03-31 | $64.72M 10-K · filed 2024-06-11 | $64.72M 10-K · filed 2022-06-23 |
| 2021-12-31 | $79.98M 10-Q · filed 2023-02-07 | |
| 2021-09-30 | $80.66M 10-Q · filed 2023-02-07 | $80.66M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $85.62M 10-Q · filed 2023-02-07 | $85.62M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $91.98M 10-K · filed 2023-06-28 | |
| 2020-12-31 | $93.81M 10-Q · filed 2022-02-10 | |
| 2020-09-30 | $4.22M 10-Q · filed 2022-02-10 | |
| 2020-06-30 | -$5.61M 10-Q · filed 2022-02-10 | |
| 2020-03-31 | -$5.73M 10-K · filed 2022-06-23 | |
| 2019-12-31 | -$6.09M 10-Q · filed 2021-02-11 | |
| 2019-09-30 | -$3.63M 10-Q · filed 2021-02-11 | |
| 2019-06-30 | $1.63M 10-Q · filed 2021-02-11 | |
| 2019-03-31 | $7.08M 10-K · filed 2021-06-29 | |
| 2018-12-31 | $1.69M 10-Q · filed 2020-02-13 | |
| 2018-09-30 | $3.99M 10-Q · filed 2020-02-13 | |
| 2018-06-30 | $3.22M 10-Q · filed 2020-02-13 | |
| 2018-03-31 | $6.92M 10-K · filed 2020-06-29 | |
| 2017-12-31 | $10.26M 10-Q · filed 2018-02-12 | |
| 2017-09-30 | -$1.67M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | -$606.80K 10-Q · filed 2017-08-14 | |
| 2017-03-31 | $615.80K 10-K · filed 2019-06-25 | |
| 2016-12-31 | $2.59M 10-Q · filed 2017-02-13 | |
| 2016-09-30 | $4.09M 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $6.16M 10-Q · filed 2016-08-12 | |
| 2016-03-31 | -$2.98M 10-K · filed 2018-06-26 | |
| 2015-12-31 | -$1.60M 10-Q · filed 2016-02-16 | |
| 2015-09-30 | -$1.32M 10-Q · filed 2015-11-16 | |
| 2015-06-30 | -$2.87M 10-Q · filed 2015-08-14 | |
| 2015-03-31 | -$20.54M 10-K · filed 2017-06-29 | |
| 2014-12-31 | -$17.78M 10-Q · filed 2015-02-17 | |
| 2014-09-30 | -$17.37M 10-Q · filed 2014-11-19 | |
| 2014-06-30 | -$15.39M 10-Q · filed 2014-08-12 | |
| 2014-03-31 | -$12.80M 10-K · filed 2016-06-24 | |
| 2013-12-31 | -$11.67M 10-Q · filed 2014-02-14 | |
| 2013-09-30 | -$12.75M 10-Q · filed 2013-11-14 | |
| 2013-06-30 | -$11.95M 10-Q · filed 2013-08-14 | |
| 2013-03-31 | -$12.56M 10-K · filed 2015-06-29 | |
| 2012-12-31 | -$10.52M 10-Q · filed 2013-02-14 | |
| 2012-09-30 | -$6.46M 10-Q · filed 2012-11-14 | |
| 2012-06-30 | -$6.28M 10-Q · filed 2012-08-14 | |
| 2012-03-31 | -$5.71M 10-K · filed 2014-06-25 | |
| 2011-12-31 | -$4.76M 10-Q · filed 2012-02-14 | |
| 2011-09-30 | -$8.72M 10-Q · filed 2011-11-14 | |
| 2011-06-30 | -$7.07M 10-Q · filed 2011-08-22 | |
| 2011-03-31 | -$32.88M 10-K · filed 2014-06-25 | -$32.88M 10-Q · filed 2011-08-22 |
| 2010-03-31 | -$26.34M 10-K · filed 2013-07-18 | |
| 2009-03-31 | -$26.68M 10-K · filed 2013-07-18 | |
| 2008-03-31 | -$22.17M 10-K · filed 2013-07-18 | |
| 2007-03-31 | -$17.45M 10-K · filed 2013-07-18 | |
| 2006-03-31 | -$16.50M 10-K · filed 2013-07-18 | |
| 2005-03-31 | -$14.74M 10-K · filed 2013-07-18 | |
| 2004-03-31 | -$13.69M 10-K · filed 2013-07-18 | |
| 2003-03-31 | -$4.95M 10-K · filed 2013-07-18 | |
| 2002-03-31 | -$4.58M 10-K · filed 2013-07-18 | |
| 2001-03-31 | -$2.51M 10-K · filed 2013-07-18 | |
| 2000-03-31 | -$844.10K 10-K · filed 2013-07-18 | |
| 1999-03-31 | -$225.50K 10-K · filed 2013-07-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |